Keto/IF Cost: Practically $0, as it only involves changing when you eat
Headline results from a REDEFINE-2 late-stage trial released earlier this month showed that Novo's next-generation CagriSema helped obese or overweight adult patients with type 2 diabetes lose 15.7% of their weight over 68 weeks, compared with 3.1% with placebo
Enriched with hydrating actives, it leaves your skin feeling fresh, smooth, and radiant for a flawless glass skin finish
A drug that is covered this year might require a PA next year, or could be removed from the formulary entirely
Its not recommended to simply stop the medication on your own
Patients have also reported a more mild sense of fullness when taking smaller doses of GLP-1s, which may help encourage consistent weight loss